Single Center Experience With Long-term Ustekinumab in Patients With Refractory Crohnʼs Disease (Prior Anti-TNF and Vedolizumab Therapy)

Autor:	Dawn B. Beaulieu, Sara N. Horst, Lauren Evers, Kim Annis, Caroline Duley, Audrey L. Bennett, Dawn W. Adams, David A. Schwartz
Rok vydání:	2017
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology Disease Single Center Vedolizumab Refractory Internal medicine Ustekinumab medicine Tumor necrosis factor alpha In patient business medicine.drug
Zdroj:	American Journal of Gastroenterology. 112:S397-S399
ISSN:	0002-9270
DOI:	10.14309/00000434-201710001-00721
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::87abbf6c58efb0e1fd295b12f663e403 https://doi.org/10.14309/00000434-201710001-00721 Zobrazit plný text záznamu